This week, the global cosmetics and personal care industry saw developments across financial performance, regulatory oversight and international expansion, as major beauty groups reported contrasting sales trends, companies adjusted their portfolios and governments introduced new measures affecting product safety and market compliance.

Financial performance presented a mixed picture across global markets. P&G reported 4 percent sales growth in fiscal Q1 2027, supported by a stronger Beauty division. Puig delivered record third-quarter sales as make-up and Asia-Pacific contributed to growth, while Dolce & Gabbana Beauty targeted double-digit growth through international expansion. In contrast, China’s online beauty sales declined 6 percent in September, with multinational brands facing weaker demand and increased competition.

Corporate results and financing activity extended beyond traditional cosmetics. THG raised its 2026 profit forecast as its nutrition business drove growth, while Walmart targeted a US$6.5 billion bond sale to support retail expansion. Malaysia’s Big Caring Pharmacy chain outlined plans for a US$600 million IPO, and Getty Images filed for bankruptcy protection amid AI competition and debt restructuring.

Portfolio restructuring and corporate strategy brought further changes. Unilever sold its Welly bandage brand to Forward Consumer Partners, while Solabia refocused its operations on cosmetics and nutraceuticals following the appointment of Muriel Koch as CEO. Proya Cosmetics opened a European innovation laboratory in France, expanding its international research and product development capabilities.

Leadership and governance changes affected several major groups. dsm-firmenich appointed Richard Ridinger Chairman of the Board, while Chanel continued its board restructuring as Bruno Pavlovsky stepped down. Dermalogica CEO Aurelian Lis announced his departure after a decade, and L’Oréal appointed its North Asia CFO to the boards of key Chinese manufacturing subsidiaries.

Source link